Bio-Rad Laboratories Class A
329 hedge funds and large institutions have $5.86B invested in Bio-Rad Laboratories Class A in 2019 Q2 according to their latest regulatory filings, with 39 funds opening new positions, 104 increasing their positions, 130 reducing their positions, and 52 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
329
Holders Change
-16
Holders Change %
-4.64%
% of All Funds
7.16%
Holding in Top 10
11
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+10%
% of All Funds
0.24%
New
39
Increased
104
Reduced
130
Closed
52
Calls
$20.4M
Puts
$4.85M
Net Calls
+$15.5M
Net Calls Change
+$18.9M
Top Buyers
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
+$46.2M |
| 2 |
Millennium Management
New York
|
+$32.8M |
| 3 |
Invesco
Atlanta,
Georgia
|
+$29.9M |
| 4 |
Nuveen Asset Management
Chicago,
Illinois
|
+$25.7M |
| 5 |
Prudential Financial
Newark,
New Jersey
|
+$20.6M |
Top Sellers
| 1 |
Acadian Asset Management
Boston,
Massachusetts
|
-$157M |
| 2 |
First Trust Advisors
Wheaton,
Illinois
|
-$29.1M |
| 3 |
N
Natixis
Paris,
France
|
-$28.5M |
| 4 |
Morgan Stanley
New York
|
-$28M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
-$26.8M |
